3741 - 3750 of 7785 Results
Title
Year
- Exposure-response efficacy model of apomorphine sublingual film for the on-demand treatment of “OFF” episodes in patients with Parkinson's disease2020RESTRICTEDTitle: Exposure-response efficacy model of apomorphine sublingual film for the on-demand treatment of “OFF” episodes in patients with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: e85End Page: e86Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.311Citation Count: 2
-
RESTRICTEDTitle: Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We?Journal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1539End Page: 1562Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1007/s13311-020-00940-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00940-4.pdfCitation Count: 23
-
RESTRICTEDTitle: Getting ahead in the race for a cure: How nonprofits are financing biomedical R&DJournal Name: Research PolicyPublisher: Elsevier BVVol: 49Issue #: 8Start Page: 104032End Page: 104032Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.respol.2020.104032Citation Count: 3
-
RESTRICTEDTitle: If LRRK2 Set the Fire, Can Nonsteroidal Anti‐inflammatory Drugs Wet the Flames?Journal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 10Start Page: 1727End Page: 1730Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28240Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28240Citation Count: 4
- Impact of Levodopa/Carbidopa Intestinal Gel Delivery on CarePartner Burden and Quality of Life: Survey by Parkinson & Movement disorder alliance2020RESTRICTEDTitle: Impact of Levodopa/Carbidopa Intestinal Gel Delivery on CarePartner Burden and Quality of Life: Survey by Parkinson & Movement disorder allianceJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: e89End Page: e90Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.325Citation Count: 0
-
RESTRICTEDTitle: Impact of OFF periods on aspects of employment for people with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: e89End Page: e89Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.323Citation Count: 1
- Long-term clinical outcomes of bilateral GPi deep brain stimulation in advanced Parkinson’s disease: 5 years and beyond2020RESTRICTEDTitle: Long-term clinical outcomes of bilateral GPi deep brain stimulation in advanced Parkinson’s disease: 5 years and beyondJournal Name: Journal of NeurosurgeryPublisher: Journal of Neurosurgery Publishing Group (JNSPG)Vol: 135Issue #: 2Start Page: 1End Page: 10Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3171/2020.6.jns20617Best OA location URL: https://thejns.org/downloadpdf/journals/j-neurosurg/aop/article-10.3171-2020.6.JNS20617/article-10.3171-2020.6.JNS20617.pdfCitation Count: 10
-
RESTRICTEDTitle: Low cerebrospinal fluid volume and the risk for post-lumbar puncture headachesJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 417Issue #:Start Page: 117059End Page: 117059Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2020.117059Citation Count: 4
- Lowering the risk of Parkinson’s disease with GLP-1 agonists and DPP4 inhibitors in type 2 diabetes2020RESTRICTEDTitle: Lowering the risk of Parkinson’s disease with GLP-1 agonists and DPP4 inhibitors in type 2 diabetesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 10Start Page: 2868End Page: 2871Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa287Best OA location URL: https://academic.oup.com/brain/article-pdf/143/10/2868/34032411/awaa287.pdfCitation Count: 8
-
RESTRICTEDTitle: Management of Tardive Syndrome: Medications and Surgical TreatmentsJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1694End Page: 1712Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00898-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00898-3.pdfCitation Count: 15